ABSTRACT
BACKGROUND: Radiation-induced hypothyroidism is a common toxicity of head and neck radiation. Our re-planning study aimed to reduce thyroid dose while maintaining target coverage with IMRT. METHODS: We retrospectively identified patients with oral-cavity (n = 5) and oropharyngeal cancer (n = 5). Treatment plans were re-optimized with 45 Gy thyroid mean dose constraint, then we cropped the thyroid out of PTVs and further reduced thyroid dose. Target coverage was delivering 100% dose to ≥ 93% of PTV and 95% of dose to > 99% of PTV. RESULTS: Originally, average mean dose to thyroid was 5580 cGy. In model I, this dropped to 4325 cGy (p < 0.0001). In model II, average mean dose was reduced to 3154 cGy (p < 0.0001). For PTV low and PTV int, all had acceptable target coverage. CONCLUSION: In patients with oral-cavity and oropharyngeal cancers, mean dose could be significantly reduced using a thyroid-optimized or thyroid-sparing IMRT technique with adequate coverage.
ABSTRACT
Enhancement of latent fingermarks found at crime scenes can be crucial to criminal investigations. The performance of ninhydrin analogues 1,2-indanedione (IND/Zn) and 1,8-diazafluoren-9-one (DFO) used in laboratories for the enhancement of latent fingermarks on porous substrates were compared for operational use. The visualisation of enhanced latent fingermarks on seven substrates commonly encountered in local crimes - plain A4 paper, glossy magazine, paper magazine, brown envelopes, white envelopes, cardboard, and joss paper were assessed using fingermarks deposits from seven donors. Fingermarks were aged under both indoor and outdoor conditions as well as over different periods of time. Our results show that IND/Zn consistently produced fingermarks of superior quality and contrast to DFO across the different donors, substrates and time periods. IND/Zn also appears to be more sensitive compared to DFO.
Subject(s)
Aza Compounds , Dermatoglyphics , Indans , Porosity , Surface Properties , Adult , Female , Humans , Male , Paper , Singapore , Time Factors , Young AdultABSTRACT
This Viewpoint discusses the value of magnetic resonance imaging with linear accelerator (MRI-linac) technology, given the unmet needs in its development.
ABSTRACT
BACKGROUND: Thyroid dysfunction is common after radiotherapy (RT) for patients with head and neck cancers. We attempted to discover RT dose parameters that correspond with RT-induced thyroid dysfunction. METHODS: Records of 102 patients who received RT from 2008 to 2010 were reviewed with respect to thyroid function. Abnormalities were grouped in 2 ways: (1) none, transient, or permanent; and (2) overt or subclinical. RESULTS: At median follow-up of 33.5 months, incidence of any thyroid abnormality was 39.2% (women vs men - 50% vs 35%). Permanent dysfunction was seen in 24.5% with higher incidence in women versus men (42.9% vs 17.6%; p = .0081). Permanent abnormalities most strongly correlated with D50% (p = .0275). V50Gy also correlated with thyroid dysfunction post-RT (p = .0316). Concurrent chemotherapy increased permanent dysfunction (p = .0008). CONCLUSION: Achieving D50% <50 Gy, V50 <50%, and mean dose <54.58 Gy during RT planning may decrease the incidence; whereas female sex and concurrent chemotherapy seem to increase the risk of RT-induced hypothyroidism. © 2016 Wiley Periodicals, Inc. Head Neck 39: 548-554, 2017.
Subject(s)
Carcinoma, Squamous Cell/radiotherapy , Head and Neck Neoplasms/radiotherapy , Hypothyroidism/etiology , Radiation Injuries/physiopathology , Radiotherapy/adverse effects , Adult , Aged , Analysis of Variance , Carcinoma, Squamous Cell/pathology , Chi-Square Distribution , Cohort Studies , Dose-Response Relationship, Radiation , Female , Head and Neck Neoplasms/pathology , Humans , Hypothyroidism/epidemiology , Hypothyroidism/physiopathology , Male , Middle Aged , Prognosis , Radiation Injuries/epidemiology , Radiation Injuries/etiology , Radiotherapy/methods , Radiotherapy Dosage , Retrospective Studies , Risk Assessment , Statistics, Nonparametric , Thyroid Diseases/epidemiology , Thyroid Diseases/etiology , Thyroid Diseases/physiopathology , Thyroid Function Tests , Thyroid Gland/physiopathology , Thyroid Gland/radiation effects , Treatment OutcomeABSTRACT
BACKGROUND: Sunflower oil is prone to oxidation during storage time, leading to production of toxic compounds that might affect human health. Synthetic antioxidants are used to prevent lipid oxidation. Spreading interest in the replacement of synthetic food antioxidants by natural ones has fostered research on fruit and vegetables for new antioxidants. METHODS: In this study, the efficacy of unripe banana peel extracts (100, 200 and 300 ppm) in stabilizing sunflower oil was tested under accelerated storage (65°C) for a period of 24 days. BHA and α-tocopherol served as comparative standards besides the control. Established parameters such as peroxide value (PV), iodine value (IV), p-anisidine value (p-AnV), total oxidation value (TOTOX), thiobarbituric acid reactive substances (TBARS) and free fatty acid (FFA) content were used to assess the extent of oil deterioration. RESULTS: After 24 days storage at 65°C, sunflower oil containing 200 and 300 ppm extract of unripe banana peel showed significantly lower PV and TOTOX compared to BHA and α-tocopherol. TBARS, p-AnV and FFA values of sunflower oil containing 200 and 300 ppm of unripe banana peel extract exhibited comparable inhibitory effects with BHA. Unripe banana peel extract at 200 and 300 ppm demonstrated inhibitory effect against both primary and secondary oxidation up to 24 days under accelerated storage conditions. CONCLUSIONS: Unripe banana peel extract may be used as a potential source of natural antioxidants in the application of food industry to suppress lipid oxidation.
Subject(s)
Antioxidants/isolation & purification , Dietary Fats, Unsaturated/analysis , Food Preservatives/isolation & purification , Industrial Waste/analysis , Musa/chemistry , Plant Extracts/isolation & purification , Plant Oils/chemistry , Aniline Compounds/analysis , Aniline Compounds/antagonists & inhibitors , Antioxidants/analysis , Antioxidants/chemistry , Antioxidants/economics , Fatty Acids, Nonesterified/analysis , Food Preservatives/analysis , Food Preservatives/chemistry , Food Preservatives/economics , Food Quality , Food Storage , Food-Processing Industry/economics , Fruit/chemistry , Fruit/growth & development , Hot Temperature , Industrial Waste/economics , Lipid Peroxidation , Lipid Peroxides/analysis , Lipid Peroxides/antagonists & inhibitors , Malaysia , Musa/growth & development , Oxidation-Reduction , Plant Extracts/chemistry , Plant Extracts/economics , Sunflower Oil , Thiobarbituric Acid Reactive Substances/analysisABSTRACT
PURPOSE: To develop a microRNA (miRNA)-based predictive model for prostate cancer patients of 1) time to biochemical recurrence after radical prostatectomy and 2) biochemical recurrence after salvage radiation therapy following documented biochemical disease progression post-radical prostatectomy. METHODS: Forty three patients who had undergone salvage radiation therapy following biochemical failure after radical prostatectomy with greater than 4 years of follow-up data were identified. Formalin-fixed, paraffin-embedded tissue blocks were collected for all patients and total RNA was isolated from 1mm cores enriched for tumor (>70%). Eight hundred miRNAs were analyzed simultaneously using the nCounter human miRNA v2 assay (NanoString Technologies; Seattle, WA). Univariate and multivariate Cox proportion hazards regression models as well as receiver operating characteristics were used to identify statistically significant miRNAs that were predictive of biochemical recurrence. RESULTS: Eighty eight miRNAs were identified to be significantly (p<0.05) associated with biochemical failure post-prostatectomy by multivariate analysis and clustered into two groups that correlated with early (≤ 36 months) versus late recurrence (>36 months). Nine miRNAs were identified to be significantly (p<0.05) associated by multivariate analysis with biochemical failure after salvage radiation therapy. A new predictive model for biochemical recurrence after salvage radiation therapy was developed; this model consisted of miR-4516 and miR-601 together with, Gleason score, and lymph node status. The area under the ROC curve (AUC) was improved to 0.83 compared to that of 0.66 for Gleason score and lymph node status alone. CONCLUSION: miRNA signatures can distinguish patients who fail soon after radical prostatectomy versus late failures, giving insight into which patients may need adjuvant therapy. Notably, two novel miRNAs (miR-4516 and miR-601) were identified that significantly improve prediction of biochemical failure post-salvage radiation therapy compared to clinico-histopathological factors, supporting the use of miRNAs within clinically used predictive models. Both findings warrant further validation studies.
Subject(s)
Biomarkers, Tumor/metabolism , MicroRNAs/metabolism , Prostatic Neoplasms/metabolism , Aged , Area Under Curve , Disease Progression , Humans , Male , Middle Aged , Prostatectomy , Prostatic Neoplasms/pathology , Prostatic Neoplasms/therapy , ROC Curve , Salvage Therapy , Treatment FailureABSTRACT
PURPOSE: Retrograde urethrography (UG) is commonly used at the time of simulation to assist in defining the prostate apex. Some investigators have reported that performing the UG introduces error by causing prostate displacement. We investigate the movement of the prostate caused by the retrograde UG. METHODS AND MATERIALS: Twenty-four patients treated with three-dimensional conformal radiotherapy for prostate cancer who had gold marker seeds placed into their prostates were studied. Marker seed locations at the time of simulation and on the portal images acquired just before the treatment were compared with the locations on digitally reconstructed radiographs (DRR). Movement in the superior-inferior and anteroposterior directions as seen on lateral images was measured from 402 portal images by offline customized imaging software and evaluated using analysis of variance methods for continuous variables and chi-square statistics for categoric variables. RESULTS: "Natural" nonrandom movement of the prostate around an "origin" as defined by markers on DRR was observed. This movement tends to be in a superior and anterior direction, with the average shift being 1 mm and 0.82 mm, respectively. The magnitude of movement in the superior direction averaged 2.88 mm compared with 1.64 mm in the inferior direction (p = 0.04). There was slightly greater movement after the UG compared with mean "natural" movement but the difference was less than 3 mm in either direction on average (difference: superior-inferior = 2.64 mm, p = 0.004; anteroposterior = 2.24, p = 0.035). CONCLUSIONS: Use of the UG induces a small but clinically insignificant displacement of the prostate when "natural" movement is taken into account.
Subject(s)
Movement , Prostate/diagnostic imaging , Prostatic Neoplasms/diagnostic imaging , Urethra/diagnostic imaging , Humans , Male , Prostatic Neoplasms/radiotherapy , Radiography , Radiotherapy Planning, Computer-Assisted , Radiotherapy, Conformal/instrumentationABSTRACT
OBJECTIVE: To determine the effectiveness of the Wyeth heptavalent pneumococcal conjugate vaccine against clinical and radiograph-confirmed pneumonia in children. METHODS: The heptavalent CRM(197) pneumococcal conjugate vaccine (PCV) was given to infants at 2, 4, 6 and 12 to 15 months of age in a randomized, double blind trial. Children were randomized to receive either the CRM(197) PCV (vaccine group) or the meningococcal type C CRM(197) conjugate vaccine (control group). The primary outcome of this trial was invasive pneumococcal disease. In addition children with the clinical diagnosis of pneumonia in the study population were identified through review of automated inpatient, emergency and outpatient databases. The subset of the cohort of these children who had chest radiographs obtained at the time of diagnosis was identified, and the original reading of their radiographs by the radiologist was obtained from automated databases. Rates of clinically diagnosed pneumonia, of pneumonia with a radiograph obtained regardless of result, of pneumonia with positive radiograph (consolidation, empyema or parenchymal infiltrate) and of pneumonia with only perihilar infiltrates were compared between vaccinated and nonvaccinated groups. In addition risk of disease pneumonia was evaluated by race and ethnicity. RESULTS: The incidence of a first pneumonia episode in the control group was 55.9 per 1000 person-years. A radiograph was obtained in 61% of episodes, a positive radiograph in 21% and perihilar findings in an additional 5%. In per protocol follow-up of children given PCV, first episodes of all clinically diagnosed pneumonia were reduced by 4.3% [95% confidence interval (CI), -3.5, 11.5%, = 0.27], episodes with a radiograph were reduced by 9.8% (CI 0.1, 18.5%, < 0.05) and episodes with a positive radiograph were reduced by 20.5% (CI 4.4, 34.0, = 0.02). In the intent to treat analysis including all episodes after randomization, episodes with a positive radiograph were reduced by 17.7%, =.01). The greatest impact was in the first year of life with a 32.2% reduction and a 23.4% reduction in the first 2 years, but only a 9.1% reduction in children >2 years of age. Asians, blacks and Hispanics were at higher risk of pneumonia than were whites, but there was no evidence of ethnic variation in PCV effectiveness. Ten of the 11 cases of pneumococcal pneumonia with a positive blood culture were in the control group. CONCLUSION: The pneumococcal conjugate vaccine tested was effective in reducing the risk of pneumonia in young children.